# Blood Test Analysis — January 2026

## Summary
Comprehensive blood work collected 21 Jan 2026 at Sullivan Nicolaides Pathology. 47 markers tested across routine chemistry, lipid profile, apolipoproteins, CRP, thyroid, hormones, metabolic markers, and full blood count.

## Key Findings

### Excellent
- CRP 0.4 mg/L — exceptional inflammation control (below Attia elite <0.5 target). Dramatic improvement: 62→16→0.4
- Testosterone 27.0 nmol/L — top quartile for age 51 (ref 11-40)
- Free Testosterone 336 pmol/L — healthy despite high SHBG
- Liver function pristine — ALT 14, GGT 15, AST 26, all well within range
- Insulin 7 mU/L — good insulin sensitivity
- Haemoglobin 156 g/L — strong, trending up
- WCC normalized (7.9) — was 10.1 H in 2019

### Needs Attention — Lipid Profile
- TC 6.1 (H) — 7-year uptrend: 4.3→4.2→5.0→6.1
- LDL 4.1 (H) — at upper reference limit
- ApoB 1.12 — above longevity targets (ESC: <1.0 moderate risk)
- Non-HDLC 4.66 (H) — significant marker per NVDPA
- Drivers: coconut oil, 4 daily eggs, red meat frequency

### Monitor
- HbA1c 5.4% — above longevity optimal <5.2 (improved from 5.5)
- Homocysteine 10.0 — above optimal <8
- eGFR 86 — recovering from 72 dip in 2024
- SHBG 76 (H) — reducing free T availability
- Urea 7.4 — trending up but in range

## Strategy
3-month lifestyle-first intervention (dietary changes: remove coconut oil, reduce eggs, increase fish, add fiber). Retest April 2026. If ApoB still >1.0, discuss pharmacological options (statin/ezetimibe) with Dr Friel. Request CAC scan to assess actual plaque burden.

## Full Report
See docs/health-report-2026-01.md for comprehensive analysis including diet-to-marker connections, exercise recommendations, supplement assessment, and expert framework cross-reference.